KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $843,381 | -9.1% | 1,359 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $927,518 | -82.7% | 1,359 | -100.0% | 0.01% | -81.2% |
| Q1 2022 | $5,349,000 | +3.6% | 6,313,000 | 0.0% | 0.06% | +73.0% |
| Q4 2021 | $5,161,000 | +57.2% | 6,313,000 | +44.7% | 0.04% | +32.1% |
| Q3 2021 | $3,284,000 | -60.4% | 4,363,000 | -33.7% | 0.03% | -61.6% |
| Q4 2020 | $8,286,000 | +24.2% | 6,579,000 | +17.9% | 0.07% | -45.1% |
| Q3 2020 | $6,671,000 | -14.7% | 5,579,000 | 0.0% | 0.13% | -48.2% |
| Q2 2020 | $7,819,000 | -10.0% | 5,579,000 | -8.0% | 0.26% | -25.1% |
| Q1 2020 | $8,689,000 | -22.5% | 6,063,000 | -22.7% | 0.34% | +68.1% |
| Q4 2019 | $11,213,000 | – | 7,845,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 8,000,000 | $5,215,000 | 9.09% |
| BRAIDWELL LP | 65,976,000 | $40,943,996 | 1.29% |
| Context Capital Management, LLC | 21,494 | $13,329 | 1.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,500,000 | $20,663,750 | 0.86% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $15,264,731 | 0.24% |
| DeepCurrents Investment Group LLC | 4,250,000 | $2,700,994 | 0.12% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,500,000 | $4,654,419 | 0.02% |
| Verition Fund Management LLC | 1,359 | $843,381 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 6,500,000 | $4,033 | 0.01% |
| BLB&B Advisors, LLC | 75,000 | $45,794 | 0.00% |